These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28280410)

  • 21. Recombinant human 5-HT3A receptors in outside-out patches of HEK 293 cells: basic properties and barbiturate effects.
    Barann M; Meder W; Dorner Z; Brüss M; Bönisch H; Göthert M; Urban BW
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Sep; 362(3):255-65. PubMed ID: 10997728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of 5-HT3 receptor-mediated ion current by divalent metal cations in NCB-20 neuroblastoma cells.
    Lovinger DM
    J Neurophysiol; 1991 Oct; 66(4):1329-37. PubMed ID: 1722246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blockage of mouse muscle nicotinic receptors by serotonergic compounds.
    García-Colunga J; Miledi R
    Exp Physiol; 1999 Sep; 84(5):847-64. PubMed ID: 10502654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Open probability of homomeric murine 5-HT3A serotonin receptors depends on subunit occupancy.
    Mott DD; Erreger K; Banke TG; Traynelis SF
    J Physiol; 2001 Sep; 535(Pt 2):427-43. PubMed ID: 11533135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrophysiological consequences of ligand binding to the desensitized 5-HT3 receptor in mammalian NG108-15 cells.
    Bartrup JT; Newberry NR
    J Physiol; 1996 Feb; 490 ( Pt 3)(Pt 3):679-90. PubMed ID: 8683467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of the BKCa channel activator, NS1619, on rat cerebral artery smooth muscle.
    Holland M; Langton PD; Standen NB; Boyle JP
    Br J Pharmacol; 1996 Jan; 117(1):119-29. PubMed ID: 8825352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding.
    Sharif NA; Wong EH; Loury DN; Stefanich E; Michel AD; Eglen RM; Whiting RL
    Br J Pharmacol; 1991 Apr; 102(4):919-25. PubMed ID: 1830236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation by calcineurin of 5-HT3 receptor function in NG108-15 neuroblastoma x glioma cells.
    Boddeke HW; Meigel I; Boeijinga P; Arbuckle J; Docherty RJ
    Br J Pharmacol; 1996 Aug; 118(7):1836-40. PubMed ID: 8842451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ethanol and trichloroethanol alter gating of 5-HT3 receptor-channels in NCB-20 neuroblastoma cells.
    Lovinger DM; Sung KW; Zhou Q
    Neuropharmacology; 2000 Feb; 39(4):561-70. PubMed ID: 10728877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetics of the membrane current mediated by serotonin 5-HT3 receptors in cultured mouse neuroblastoma cells.
    Neijt HC; Plomp JJ; Vijverberg HP
    J Physiol; 1989 Apr; 411():257-69. PubMed ID: 2482354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The interaction of trichloroethanol with murine recombinant 5-HT3 receptors.
    Downie DL; Hope AG; Belelli D; Lambert JJ; Peters JA; Bentley KR; Steward LJ; Chen CY; Barnes NM
    Br J Pharmacol; 1995 Apr; 114(8):1641-51. PubMed ID: 7541281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tetraethylammonium ions block 5-HT3 receptor-mediated ion current at the agonist recognition site and prevent desensitization in cultured mouse neuroblastoma cells.
    Kooyman AR; Zwart R; Vijverberg HP
    Eur J Pharmacol; 1993 Aug; 246(3):247-54. PubMed ID: 7693498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allosteric potentiation of the 5-HT3 receptor-mediated ion current in N1E-115 neuroblastoma cells by 5-hydroxyindole and analogues.
    van Hooft JA; van der Haar E; Vijverberg HP
    Neuropharmacology; 1997; 36(4-5):649-53. PubMed ID: 9225290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5-Hydroxyindole slows desensitization of the 5-HT3 receptor-mediated ion current in N1E-115 neuroblastoma cells.
    Kooyman AR; van Hooft JA; Vijverberg HP
    Br J Pharmacol; 1993 Feb; 108(2):287-9. PubMed ID: 7680589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct inhibition of 5-hydroxytryptamine3 receptors by antagonists of L-type Ca2+ channels.
    Hargreaves AC; Gunthorpe MJ; Taylor CW; Lummis SC
    Mol Pharmacol; 1996 Nov; 50(5):1284-94. PubMed ID: 8913360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diltiazem causes open channel block of recombinant 5-HT3 receptors.
    Gunthorpe MJ; Lummis SC
    J Physiol; 1999 Sep; 519 Pt 3(Pt 3):713-22. PubMed ID: 10457085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of 5-HT3 receptors by propofol: equilibrium and kinetic measurements.
    Barann M; Dilger JP; Bönisch H; Göthert M; Dybek A; Urban BW
    Neuropharmacology; 2000 Apr; 39(6):1064-74. PubMed ID: 10727717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of morphine on human 5-HT3A receptors.
    Wittmann M; Peters I; Schaaf T; Wartenberg HC; Wirz S; Nadstawek J; Urban BW; Barann M
    Anesth Analg; 2006 Sep; 103(3):747-52. PubMed ID: 16931691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An electrophysiological investigation of the properties of a murine recombinant 5-HT3 receptor stably expressed in HEK 293 cells.
    Gill CH; Peters JA; Lambert JJ
    Br J Pharmacol; 1995 Mar; 114(6):1211-21. PubMed ID: 7620711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular actions of propofol on human 5-HT3A receptors: enhancement as well as inhibition by closely related phenol derivatives.
    Barann M; Linden I; Witten S; Urban BW
    Anesth Analg; 2008 Mar; 106(3):846-57, table of contents. PubMed ID: 18292429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.